Magnetic Hyperthermia in Dendritic Cells and Magnetofection in Brain Cells

Magnetic Hyperthermia in Dendritic Cells and Magnetofection in Brain Cells

Tesis Doctoral BIOMEDICAL APPLICATIONS OF MAGNETIC NANOPARTICLES: MAGNETIC HYPERTHERMIA IN DENDRITIC CELLS AND MAGNETOFECTION IN BRAIN CELLS Autor Asín Pardo, Laura Director/es Ibarra García, Manuel Ricardo Goya Rossetti, Gerardo Fabián FACULTAD DE CIENCIAS Departamento de Física de la Materia Condensada 2012 Repositorio de la Universidad de Zaragoza – Zaguan http://zaguan.unizar.es BIOMEDICAL APPLICATIONS OF MAGNETIC NANOPARTICLES: MAGNETIC HYPERTHERMIA IN DENDRITIC CELLS AND MAGNETOFECTION IN BRAIN CELLS. Memoria presentada para optar al grado de Doctor Europeo por la Universidad de Zaragoza Laura Asín Pardo Directores: M. Ricardo Ibarra Gerardo F. Goya Departamento de Física de la Materia Condensada Zaragoza, Marzo 2012. 1 Index Index .......................................................................................................................... 1 Abbreviations ............................................................................................................ 5 Preface ....................................................................................................................... 8 I. Introduction .................................................................................................... 11 I.I. Nanoscience and nanoparticles ............................................................. 13 I.II. Magnetism basis ................................................................................... 17 I.III. Magnetic hyperthermia ......................................................................... 26 I.IV. Dendritic cells ....................................................................................... 35 I.V. Magnetofection ..................................................................................... 47 II. Materials & Methods ...................................................................................... 53 II.I. AMF experiments in dendritic cells ..................................................... 55 II.I.I. Magnetic nanoparticles .................................................................. 56 II.I.II. Dendritic cells culture and MNPs loading ................................... 59 II.I.III. Viability assay ............................................................................. 62 II.I.IV. Maturation markers expression measurement by FACS ............ 67 II.I.V. Cytokines expression analysis ..................................................... 68 II.I.VI. Quantification of MNPs loaded per cell ..................................... 70 II.I.VII. Internalization study by FACS .................................................. 72 II.I.VIII. AMF application experiments .................................................. 72 II.I.IX. Scanning electron microscopy .................................................... 75 II.I.X. Transmission electron microscopy............................................... 76 II.I.XI. Dual Beam .................................................................................. 77 II.I.XII. Confocal microscopy ................................................................. 78 II.I.XIII. Western-Blot ............................................................................ 80 2 II.II. Preparation of Adenovirus-MNPs complexes for magnetofection ........ 83 II.II.I. Cell lines ....................................................................................... 84 II.II.II. Magnetic nanoparticles ............................................................... 85 II.II.III. Adenovirus titration ................................................................... 87 II.II.IV. Adenovirus-MNPs complexes association and stability study.. 88 II.II.V. Size, Z-potential and magnetic responsiveness measurements for complexes ............................................................................................... 90 II.II.VI. AFM .......................................................................................... 91 II.II.VII. TEM ......................................................................................... 92 II.II.VIII. Complexes internalization ...................................................... 92 II.II.IX. Viability assay ........................................................................... 94 II.II.X. Infection experiments ................................................................. 94 III. Results & Discussion ...................................................................................... 97 III-I: DCs and MNPs interaction .................................................................... 99 III.I.I. Characterization of the magnetic nanoparticles ......................... 101 III.I.II. DCs differentiation from PBMCs ............................................. 109 III.I.III. Viability assay ......................................................................... 111 III.I.IV. TEM......................................................................................... 117 III.I.V. SEM .......................................................................................... 120 III.I.VI. Dual Beam ............................................................................... 124 III.I.VII. Confocal microscopy ............................................................. 126 III.I.VIII. Quantification ....................................................................... 131 III.I.IX. Internalization study by FACS ................................................ 138 III.I.X. Membrane molecules expression profile .................................. 140 III.I.XI. Cytokine expression ................................................................ 147 III.I.XII. Conclusions ............................................................................ 150 III-II: Magnetic Fluid Hyperthermia in DCs ................................................ 151 III.II.I. AMF effect ............................................................................... 153 3 III.II.II. HSP-70 expression .................................................................. 167 III.II.III. SEM ........................................................................................ 169 III.II.IV. Conclusions ............................................................................ 171 III-III: Preparation of Adenovirus-MNPs complexes for magnetofection ... 173 III.III.I. Magnetic nanoparticles ............................................................ 175 III.III.II. Virus titration ......................................................................... 180 III.III.III. Adenovirus-MNPs complexes association and stability ....... 184 III.III.IV. Size, Z-potential and magnetophoretic measurements ......... 186 III.III.V. Morphological characterization of the complexes ................. 193 III.III.VI. Complex internalization ........................................................ 198 III.III.VII. Viability assay ..................................................................... 201 III.III.VIII. Infection experiments ......................................................... 203 III.III.IX. Coculture infections .............................................................. 208 III.III.X. In vivo preliminary results ..................................................... 211 III.III.XI. Conclusions........................................................................... 213 IV. Conclusions .................................................................................................. 215 Bibliography .......................................................................................................... 219 Annexe : Theoretical basis of techniques .............................................................. 235 VI.I. Specific Power Absorption ........................................................... 237 VI.II. Dynamic Light Scattering ........................................................... 239 VI.III. SEM ........................................................................................... 241 VI.IV. TEM ........................................................................................... 243 VI.V. Dual Beam .................................................................................. 244 VI.VI. Confocal .................................................................................... 246 4 Abbreviations AC: alternating current AMF: alternating magnetic field APC: antigen presenting cell BSA: bovine serum albumine CD40L: CD40 ligando CPM: counts per minute CSF: cerebrospinal fluid DCs: dendritic cells iDCs: immature dendritic cells mDCs: mature DCs ECs: endothelial cells FBS: fetal bovine serum FCS: fetal calf serum FM: ferro or ferromagnetic FSA: fluorinated surfactant FSC: Forward Scatter G. lucidum: Ganoderma lucidum GFP: green fluorescence protein GM-CSF: granulocyte-macrophage colony-stimulating factor H: magnetic field Hc: coercitivity field IL: interleukin 5 Abbreviations ________________________________________________ INF-γ: interferon γ LPS: Lipopolysaccharides M: magnetization Ms: saturation magnetization Mr: remanence magnetization M-CSF: macrophage colony-stimulating factor MD: multi-domain MFH: magnetic fluid hyperthermia MFI: mean fluorescence intensity MNPs: magnetic nanoparticles MOI: multiplicities of infection MPs: micro particles NPs: nanoparticles MRI: magnetic resonance imaging PBS: Phosphate buffered saline PCS: photon correlation spectroscopy PEI: polyethylenimine PGA: poly-glutamic acid PGE2: prostaglandina E2 PLGA RT: room temperature SD: single-domain

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    248 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us